Corient Private Wealth LP Takes $1.21 Million Position in Surgery Partners, Inc. $SGRY

Corient Private Wealth LP bought a new position in shares of Surgery Partners, Inc. (NASDAQ:SGRY) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 72,056 shares of the company’s stock, valued at approximately $1,211,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in SGRY. State of Wisconsin Investment Board raised its stake in Surgery Partners by 0.4% during the fourth quarter. State of Wisconsin Investment Board now owns 151,504 shares of the company’s stock worth $2,341,000 after buying an additional 668 shares during the last quarter. ProShare Advisors LLC raised its position in shares of Surgery Partners by 6.9% during the fourth quarter. ProShare Advisors LLC now owns 14,135 shares of the company’s stock worth $218,000 after purchasing an additional 909 shares during the period. California State Teachers Retirement System lifted its holdings in shares of Surgery Partners by 1.6% in the 2nd quarter. California State Teachers Retirement System now owns 65,091 shares of the company’s stock worth $1,447,000 after purchasing an additional 1,021 shares in the last quarter. Sanctuary Advisors LLC lifted its holdings in shares of Surgery Partners by 4.5% in the 4th quarter. Sanctuary Advisors LLC now owns 28,488 shares of the company’s stock worth $440,000 after purchasing an additional 1,218 shares in the last quarter. Finally, Empowered Funds LLC raised its holdings in Surgery Partners by 11.0% during the first quarter. Empowered Funds LLC now owns 12,853 shares of the company’s stock worth $305,000 after buying an additional 1,278 shares during the last quarter.

Insiders Place Their Bets

In related news, Director Teresa DeLuca bought 10,000 shares of the company’s stock in a transaction on Tuesday, August 18th. The stock was acquired at an average cost of $14.35 per share, for a total transaction of $143,500.00. Following the completion of the transaction, the director directly owned 66,843 shares in the company, valued at $959,197.05. This trade represents a 17.59% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 2.00% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

SGRY has been the subject of a number of recent research reports. Zacks Research lowered Surgery Partners from a “strong-buy” rating to a “hold” rating in a report on Monday, August 10th. Raymond James Financial set a $18.00 target price on Surgery Partners in a research report on Tuesday, August 11th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $18.00 target price on shares of Surgery Partners in a report on Tuesday, August 11th. TD Cowen raised their price target on shares of Surgery Partners from $17.00 to $19.00 and gave the company a “buy” rating in a research report on Tuesday, August 11th. Finally, Benchmark reaffirmed a “buy” rating on shares of Surgery Partners in a research report on Tuesday, August 11th. Seven research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Surgery Partners has a consensus rating of “Moderate Buy” and a consensus price target of $19.45.

Surgery Partners Trading Up 0.6%

Shares of SGRY opened at $14.26 on Friday. The business’s 50-day moving average price is $15.40 and its 200-day moving average price is $14.37. Surgery Partners, Inc. has a twelve month low of $11.41 and a twelve month high of $23.44. The stock has a market cap of $1.87 billion, a PE ratio of -20.37, a P/E/G ratio of 4.37 and a beta of 1.92. The company has a quick ratio of 1.78, a current ratio of 1.95 and a debt-to-equity ratio of 1.18.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings data on Monday, August 10th. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.06 by $0.04. Surgery Partners had a negative net margin of 2.63% and a positive return on equity of 0.88%. The company had revenue of $848.90 million during the quarter, compared to analyst estimates of $830.03 million. During the same period last year, the business earned $0.17 earnings per share. Surgery Partners’s revenue was up 2.7% compared to the same quarter last year. On average, equities analysts forecast that Surgery Partners, Inc. will post 0.22 EPS for the current fiscal year.

Surgery Partners Profile

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.